Literature DB >> 31018715

Toxicity induced by multiple high doses of vitamin B12 during pernicious anemia treatment: a case report.

Jessica Morales-Gutierrez1, Sebastián Díaz-Cortés1, María A Montoya-Giraldo1, Andres F Zuluaga1.   

Abstract

CONTEXT: The clinical consequences of excess vitamin B12 induced by multiple oral doses of cyanocobalamin are not well-known. CASE DETAILS: A young woman was treated with multiple daily doses of 1 mg of cyanocobalamin for severe pernicious anemia. After a total dose of 12 mg, she developed acne, palpitations, anxiety, akathisia, facial ruddiness, headache, and insomnia. She improved two weeks after stopping the drug. There were no sequelae nor complications. DISCUSSION: Although these symptoms of cobalamin toxicity were unexpected and unusual, the case reminds us that the administration of any drug is not entirely safe.

Entities:  

Keywords:  Cyanocobalamin; maximum acceptable dose; pharmacology; poisoning; toxicity

Year:  2019        PMID: 31018715     DOI: 10.1080/15563650.2019.1606432

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  3 in total

1.  Vomiting as a Presenting Symptom of Infantile Vitamin B12 Deficiency.

Authors:  Sienna Wong; Nabeeha Ahmad; Allison L Rossetti
Journal:  Cureus       Date:  2022-05-19

Review 2.  Nutraceuticals for Peripheral Vestibular Pathology: Properties, Usefulness, Future Perspectives and Medico-Legal Aspects.

Authors:  Giuseppe Chiarella; Gianmarco Marcianò; Pasquale Viola; Caterina Palleria; Davide Pisani; Vincenzo Rania; Alessandro Casarella; Alessia Astorina; Alfonso Scarpa; Massimiliano Esposito; Monica Salerno; Nunzio Di Nunno; Matteo Bolcato; Amalia Piscopo; Erika Cione; Giovambattista De Sarro; Giulio Di Mizio; Luca Gallelli
Journal:  Nutrients       Date:  2021-10-18       Impact factor: 6.706

Review 3.  Current Nanocarrier Strategies Improve Vitamin B12 Pharmacokinetics, Ameliorate Patients' Lives, and Reduce Costs.

Authors:  Marco Fidaleo; Stefano Tacconi; Carolina Sbarigia; Daniele Passeri; Marco Rossi; Ada Maria Tata; Luciana Dini
Journal:  Nanomaterials (Basel)       Date:  2021-03-16       Impact factor: 5.076

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.